Arrowhead Pharmaceuticals, Inc. annual revenue for fiscal 2025 was $829 million, an increase of 22,938.9% from $4 million in fiscal 2024. All figures are reported results from public filings — no estimates or projections.
| Revenue (annual) | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Total Revenue | $829M | $4M | $241M | $243M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Revenue (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $74M | $264M | $256M | $28M | $543M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More ARWR metrics: Operating Income · Net Income · EPS · Free Cash Flow
All ARWR financial statements → Interactive ARWR charts →
About TickerBase · Data methodology & sources